Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid
Publication
, Conference
Ridpath, A; Rzepka, P; Shearer, S; Pignotti, BK; Scrape, S; Olencki, T; Kaffenberger, B
Duke Scholars
Conference Name
: 34th Annual Meeting of the Ohio Dermatological Association
Citation
APA
Chicago
ICMJE
MLA
NLM
Ridpath, A., Rzepka, P., Shearer, S., Pignotti, B. K., Scrape, S., Olencki, T., & Kaffenberger, B. (n.d.). Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid. Presented at the : 34th Annual Meeting of the Ohio Dermatological Association.
Ridpath, Alyson, Polina Rzepka, Sabrina Shearer, B. K. Pignotti, Scott Scrape, Thomas Olencki, and Benjamin Kaffenberger. “Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid,” n.d.
Ridpath A, Rzepka P, Shearer S, Pignotti BK, Scrape S, Olencki T, et al. Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid. In.
Ridpath A, Rzepka P, Shearer S, Pignotti BK, Scrape S, Olencki T, Kaffenberger B. Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid.
Conference Name
: 34th Annual Meeting of the Ohio Dermatological Association